Medication info

Imprida Tablet 5/80 mg

Prescription medicationApproval withdrawn
Ingredient · strength
Valsartan›Strength being verifiedAmlodipine Besylate›Strength being verified
Manufacturer / importer
SANDOZ KOREA
Appearance
Dark yellow round film-coated tablet
Packaging
28 tablets (14 tablets/PTP packaging X 2)
Approval status
Approval withdrawn

MFDS item code 201305047 · Approved 2013.02.15

This product's status changed to Approval withdrawn on 2023.06.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who uses it
Adults · Children
Adult dosage
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medication may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance at least 10mL/min). However, this medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medication should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose.
Children's dosage
The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Importer
SANDOZ KOREA

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled with either amlodipine or valsartan monotherapy.

Dosage and Administration

Adult dosage

The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medication may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance at least 10mL/min). However, this medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medication should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose.

Children's dosage

The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to any of the ingredients or similar medications, pregnant or nursing women, or patients with severe renal or hepatic dysfunction. Patients with sodium or fluid depletion should correct their condition before taking this medication and carefully observe blood pressure and symptoms during treatment. Patients with high potassium levels or those taking potassium supplements or potassium-sparing diuretics should frequently monitor potassium levels. Patients with renal issues or those who have received a kidney transplant should monitor renal function changes while taking this medication. If symptoms of angioedema occur, the medication should be discontinued immediately and not resumed. Patients with heart failure or those who have had a myocardial infarction should regularly assess renal function during therapy with this medication. This medication is not recommended for children as its safety and efficacy have not been established in this population. Elderly individuals can take the usual adult dosage, but they should be monitored carefully. Caution is advised as dizziness or fatigue may occur when driving or operating machinery. In case of overdose, symptoms such as hypotension and reduced cardiac function may occur, and immediate medical attention should be sought for appropriate treatment. This medication may interact with other antihypertensive drugs, potassium supplements, certain diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), and lithium preparations, so it is essential to consult with a physician or pharmacist before taking them together. Women planning to become pregnant or who may be pregnant should consult a doctor before taking this medication, and nursing mothers are advised to avoid it.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, lumbago, arthritis, muscle spasms, lethargy, pollakiuria, polyuria, erectile dysfunction, edema, lymphatic edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, elevated serum potassium, vasculitis, elevated liver function tests, angioedema, vesicular dermatitis, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disorder, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival polymorphism, gastritis, neuroexcitation, sensory impairment, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is safe to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Dark yellow round film-coated tablet

Package unit

28 tablets (14 tablets/PTP packaging X 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.